Study Protocol for a Prospective Observational Study to Evaluate the Efficacy of Fosnetupitant for Long-Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Platinum-Based Chemotherapy (LODEC-N)
delayed Complete Response (CR) rate, defined as the proportion of patients experiencing no emesis without rescue medication, and an overall (0 h–336 h) CC, CR, and total control rates ... analysis is planned according…

